How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
35
AVDL Quote, Financials, Valuation and Earnings
Last price:
$7.85
Seasonality move
:
2.92%
Day range:
$7.76 - $8.05
52-week range:
$7.39 - $19.09
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.41x
P/B ratio:
10.26x
Volume:
689.6K
Avg. volume:
1.1M
1-year change:
-53.58%
Market cap:
$757.6M
Revenue:
$169.1M
EPS (TTM):
-$0.52
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
$50.5M | -$0.07 | 85.81% | -78.33% | $17.70 |
|
ALKS
Alkermes PLC
|
$311.1M | $0.30 | -11.22% | 41.72% | $39.20 |
|
AMRN
Amarin Corp PLC
|
$50.3M | -$0.02 | -11.04% | -- | $1.00 |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$984.3M | $4.82 | 9.16% | 309.21% | $193.22 |
|
MDT
Medtronic PLC
|
$8.3B | $1.36 | 2.61% | 221.83% | $97.05 |
|
PRGO
Perrigo Co PLC
|
$1.1B | $0.54 | 0.89% | 5337.6% | $34.60 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
$7.84 | $17.70 | $757.6M | -- | $0.00 | 0% | 4.41x |
|
ALKS
Alkermes PLC
|
$33.03 | $39.20 | $5.4B | 15.22x | $0.00 | 0% | 3.59x |
|
AMRN
Amarin Corp PLC
|
$0.45 | $1.00 | $187M | -- | $0.00 | 0% | 0.81x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$124.15 | $193.22 | $7.5B | 14.12x | $0.00 | 0% | 1.96x |
|
MDT
Medtronic PLC
|
$89.86 | $97.05 | $115.2B | 27.31x | $0.70 | 3.12% | 3.51x |
|
PRGO
Perrigo Co PLC
|
$28.04 | $34.60 | $3.8B | -- | $0.29 | 3.99% | 0.88x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
-- | -2.475 | -- | 2.21x |
|
ALKS
Alkermes PLC
|
-- | 1.083 | -- | 2.45x |
|
AMRN
Amarin Corp PLC
|
-- | 0.021 | -- | 2.31x |
|
JAZZ
Jazz Pharmaceuticals PLC
|
59.88% | 0.953 | 81.81% | 3.57x |
|
MDT
Medtronic PLC
|
34.97% | 0.718 | 22.74% | 1.19x |
|
PRGO
Perrigo Co PLC
|
45.58% | -0.127 | 103.15% | 1.15x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals PLC
|
$45.6M | -$3.3M | -63.43% | -63.43% | -4.49% | $7.9M |
|
ALKS
Alkermes PLC
|
$367.9M | $162.7M | 23.97% | 28.24% | 40.59% | $180.6M |
|
AMRN
Amarin Corp PLC
|
-$9.6M | -$52.5M | -15.41% | -15.41% | -60.86% | -$13.3M |
|
JAZZ
Jazz Pharmaceuticals PLC
|
$959.5M | $190.8M | 5.74% | 14.39% | 16.95% | $385.3M |
|
MDT
Medtronic PLC
|
$5.5B | $1.7B | 5.58% | 8.56% | 20.73% | $2.1B |
|
PRGO
Perrigo Co PLC
|
$385.9M | $164.8M | -1.98% | -3.76% | 9.94% | $274.9M |
Avadel Pharmaceuticals PLC vs. Competitors
-
Which has Higher Returns AVDL or ALKS?
Alkermes PLC has a net margin of -10% compared to Avadel Pharmaceuticals PLC's net margin of 34.07%. Avadel Pharmaceuticals PLC's return on equity of -63.43% beat Alkermes PLC's return on equity of 28.24%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC90.45% -$0.05 $73.8M ALKSAlkermes PLC85.55% $0.88 $1.5B -
What do Analysts Say About AVDL or ALKS?
Avadel Pharmaceuticals PLC has a consensus price target of $17.70, signalling upside risk potential of 125.77%. On the other hand Alkermes PLC has an analysts' consensus of $39.20 which suggests that it could grow by 18.7%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Alkermes PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Alkermes PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC7 0 0 ALKSAlkermes PLC8 6 0 -
Is AVDL or ALKS More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.518, which suggesting that the stock is 51.783% more volatile than S&P 500. In comparison Alkermes PLC has a beta of 0.389, suggesting its less volatile than the S&P 500 by 61.108%.
-
Which is a Better Dividend Stock AVDL or ALKS?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alkermes PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Alkermes PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or ALKS?
Avadel Pharmaceuticals PLC quarterly revenues are $50.4M, which are smaller than Alkermes PLC quarterly revenues of $430M. Avadel Pharmaceuticals PLC's net income of -$5M is lower than Alkermes PLC's net income of $146.5M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Alkermes PLC's PE ratio is 15.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 4.41x versus 3.59x for Alkermes PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC4.41x -- $50.4M -$5M ALKSAlkermes PLC3.59x 15.22x $430M $146.5M
-
Which has Higher Returns AVDL or AMRN?
Amarin Corp PLC has a net margin of -10% compared to Avadel Pharmaceuticals PLC's net margin of -78.03%. Avadel Pharmaceuticals PLC's return on equity of -63.43% beat Amarin Corp PLC's return on equity of -15.41%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC90.45% -$0.05 $73.8M AMRNAmarin Corp PLC-15.36% -$0.12 $486.2M -
What do Analysts Say About AVDL or AMRN?
Avadel Pharmaceuticals PLC has a consensus price target of $17.70, signalling upside risk potential of 125.77%. On the other hand Amarin Corp PLC has an analysts' consensus of $1.00 which suggests that it could grow by 121.48%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Amarin Corp PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Amarin Corp PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC7 0 0 AMRNAmarin Corp PLC0 1 0 -
Is AVDL or AMRN More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.518, which suggesting that the stock is 51.783% more volatile than S&P 500. In comparison Amarin Corp PLC has a beta of 1.381, suggesting its more volatile than the S&P 500 by 38.057%.
-
Which is a Better Dividend Stock AVDL or AMRN?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amarin Corp PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Amarin Corp PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or AMRN?
Avadel Pharmaceuticals PLC quarterly revenues are $50.4M, which are smaller than Amarin Corp PLC quarterly revenues of $62.3M. Avadel Pharmaceuticals PLC's net income of -$5M is higher than Amarin Corp PLC's net income of -$48.6M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Amarin Corp PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 4.41x versus 0.81x for Amarin Corp PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC4.41x -- $50.4M -$5M AMRNAmarin Corp PLC0.81x -- $62.3M -$48.6M
-
Which has Higher Returns AVDL or JAZZ?
Jazz Pharmaceuticals PLC has a net margin of -10% compared to Avadel Pharmaceuticals PLC's net margin of 17.56%. Avadel Pharmaceuticals PLC's return on equity of -63.43% beat Jazz Pharmaceuticals PLC's return on equity of 14.39%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC90.45% -$0.05 $73.8M JAZZJazz Pharmaceuticals PLC88.17% $3.11 $10.2B -
What do Analysts Say About AVDL or JAZZ?
Avadel Pharmaceuticals PLC has a consensus price target of $17.70, signalling upside risk potential of 125.77%. On the other hand Jazz Pharmaceuticals PLC has an analysts' consensus of $193.22 which suggests that it could grow by 55.64%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Jazz Pharmaceuticals PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Jazz Pharmaceuticals PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC7 0 0 JAZZJazz Pharmaceuticals PLC9 2 0 -
Is AVDL or JAZZ More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.518, which suggesting that the stock is 51.783% more volatile than S&P 500. In comparison Jazz Pharmaceuticals PLC has a beta of 0.419, suggesting its less volatile than the S&P 500 by 58.096%.
-
Which is a Better Dividend Stock AVDL or JAZZ?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Jazz Pharmaceuticals PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Jazz Pharmaceuticals PLC pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or JAZZ?
Avadel Pharmaceuticals PLC quarterly revenues are $50.4M, which are smaller than Jazz Pharmaceuticals PLC quarterly revenues of $1.1B. Avadel Pharmaceuticals PLC's net income of -$5M is lower than Jazz Pharmaceuticals PLC's net income of $191.1M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Jazz Pharmaceuticals PLC's PE ratio is 14.12x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 4.41x versus 1.96x for Jazz Pharmaceuticals PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC4.41x -- $50.4M -$5M JAZZJazz Pharmaceuticals PLC1.96x 14.12x $1.1B $191.1M
-
Which has Higher Returns AVDL or MDT?
Medtronic PLC has a net margin of -10% compared to Avadel Pharmaceuticals PLC's net margin of 15.61%. Avadel Pharmaceuticals PLC's return on equity of -63.43% beat Medtronic PLC's return on equity of 8.56%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC90.45% -$0.05 $73.8M MDTMedtronic PLC66.49% $1.01 $76.2B -
What do Analysts Say About AVDL or MDT?
Avadel Pharmaceuticals PLC has a consensus price target of $17.70, signalling upside risk potential of 125.77%. On the other hand Medtronic PLC has an analysts' consensus of $97.05 which suggests that it could grow by 8.01%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Medtronic PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Medtronic PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC7 0 0 MDTMedtronic PLC11 14 1 -
Is AVDL or MDT More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.518, which suggesting that the stock is 51.783% more volatile than S&P 500. In comparison Medtronic PLC has a beta of 0.794, suggesting its less volatile than the S&P 500 by 20.554%.
-
Which is a Better Dividend Stock AVDL or MDT?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Medtronic PLC offers a yield of 3.12% to investors and pays a quarterly dividend of $0.70 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Medtronic PLC pays out 99.73% of its earnings as a dividend. Medtronic PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AVDL or MDT?
Avadel Pharmaceuticals PLC quarterly revenues are $50.4M, which are smaller than Medtronic PLC quarterly revenues of $8.3B. Avadel Pharmaceuticals PLC's net income of -$5M is lower than Medtronic PLC's net income of $1.3B. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Medtronic PLC's PE ratio is 27.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 4.41x versus 3.51x for Medtronic PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC4.41x -- $50.4M -$5M MDTMedtronic PLC3.51x 27.31x $8.3B $1.3B
-
Which has Higher Returns AVDL or PRGO?
Perrigo Co PLC has a net margin of -10% compared to Avadel Pharmaceuticals PLC's net margin of -3.91%. Avadel Pharmaceuticals PLC's return on equity of -63.43% beat Perrigo Co PLC's return on equity of -3.76%.
Company Gross Margin Earnings Per Share Invested Capital AVDLAvadel Pharmaceuticals PLC90.45% -$0.05 $73.8M PRGOPerrigo Co PLC33.9% -$0.32 $7.9B -
What do Analysts Say About AVDL or PRGO?
Avadel Pharmaceuticals PLC has a consensus price target of $17.70, signalling upside risk potential of 125.77%. On the other hand Perrigo Co PLC has an analysts' consensus of $34.60 which suggests that it could grow by 23.4%. Given that Avadel Pharmaceuticals PLC has higher upside potential than Perrigo Co PLC, analysts believe Avadel Pharmaceuticals PLC is more attractive than Perrigo Co PLC.
Company Buy Ratings Hold Ratings Sell Ratings AVDLAvadel Pharmaceuticals PLC7 0 0 PRGOPerrigo Co PLC1 3 0 -
Is AVDL or PRGO More Risky?
Avadel Pharmaceuticals PLC has a beta of 1.518, which suggesting that the stock is 51.783% more volatile than S&P 500. In comparison Perrigo Co PLC has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.326%.
-
Which is a Better Dividend Stock AVDL or PRGO?
Avadel Pharmaceuticals PLC has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perrigo Co PLC offers a yield of 3.99% to investors and pays a quarterly dividend of $0.29 per share. Avadel Pharmaceuticals PLC pays -- of its earnings as a dividend. Perrigo Co PLC pays out -88.77% of its earnings as a dividend.
-
Which has Better Financial Ratios AVDL or PRGO?
Avadel Pharmaceuticals PLC quarterly revenues are $50.4M, which are smaller than Perrigo Co PLC quarterly revenues of $1.1B. Avadel Pharmaceuticals PLC's net income of -$5M is higher than Perrigo Co PLC's net income of -$44.5M. Notably, Avadel Pharmaceuticals PLC's price-to-earnings ratio is -- while Perrigo Co PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avadel Pharmaceuticals PLC is 4.41x versus 0.88x for Perrigo Co PLC. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AVDLAvadel Pharmaceuticals PLC4.41x -- $50.4M -$5M PRGOPerrigo Co PLC0.88x -- $1.1B -$44.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 7.87% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 0.85% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 1.51% over the past day.
